Kauppalehti

Development Policy Committee’s discussion paper: Businesses need stronger incentives and fewer obstacles in development financing

This is highlighted in the discussion paper on incentives and stumbling blocks for development finance, commissioned by the Development Policy Committee (DPC).
Kauppalehti

Kamux Corporation’s Board of Directors has decided on the new earning periods for the long-term incentive plans 2026–2028

February 25, 2026 at 08:40:00 EET. The Board of Directors of Kamux Corporation has decided on new earning periods for the Performance ...
Kauppalehti

Facephi Enters the Japanese Identity and Fraud-Prevention Market via Hancom

Facephi Enters the Japanese Identity and Fraud-Prevention Market via Hancom Cyberlinks (TSE Tokyo: 3683), a Japanese cloud services provider, has adopted Hancom AUTH, a SDK/platform for identity ...
Kauppalehti

Statkraft signs contract with OX2 to optimize large-scale batteries in Finland

(Oslo/Espoo, 25 February 2026) Statkraft and Swedish developer OX2 have signed a seven-year, 235-MW battery energy storage agreement in Finland. This is Statkraft’s largest BESS PPA in the Nordics to ...
Kauppalehti

Notice to the Annual General Meeting of Kreate Group Plc

Notice to general meeting. The shareholders of Kreate Group Plc (hereinafter referred to as “Kreate”) are invited to attend ...
Kauppalehti

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)

JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...
Kauppalehti

Teva to Present at the Upcoming Investor Conferences in March

To access live webcasts of the presentations, please visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations . Archived versions of the webcasts will be available ...
Kauppalehti

Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and ...
Kauppalehti

Countdown For A Cure Raises Over $1 Million at 2026 Evening of Energy Gala

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Countdown For A Cure (CFAC) hosted its third annual Evening of Energy gala on February 7th at The St. Regis Atlanta, raising more than $1 million to advance ...
Kauppalehti

KDventures’s portfolio company SVF Vaccines announces that the intended merger with Novakand will not be carried out following negative decision from Nasdaq

STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be ...
Kauppalehti

Brookfield Launches Radiant as first vertically integrated AI Infrastructure Company Through Merger with Ori Industries

Radiant becomes one of the world’s first infrastructure companies engineered from the ground up to deliver integrated AI compute. Radiant’s access to scaled capital from Brookfield, alongside data ...
Kauppalehti

Sompo Completes Acquisition of Aspen

Following its acquisition by Sompo, Aspen will come under the Sompo Group umbrella and will transition to trading under the Sompo brand. Following the transaction, Mark Cloutier will act in an ...